Oncology (ONC) Community

Community Goals

  • Provide forums for interactions of Community members to foster new relationships and provide interactive scientific discussion on current key issues in oncology.
  • Develop of best practices for Annual Meeting scientific programming proposals that leads to scientifically rich, well-developed collaborative proposals issues in oncology.
  • Utilize social media to post impactful publications or presentations, permit commentary, and promote discussion among members.
  • Standardize criteria to prioritize scientific proposals in collaboration with members of other Communities housed within the Translational & Precision Network.

Join the LinkedIn Group.

ASCPT 2019 Annual Meeting
Oncology and Pharmacogenomics Joint Community Meeting
Thursday, March 14 (7:00 am - 8:00 am)
Maryland Room
Despite the promise of personalized medicine, there has been uneven uptake across therapeutic areas. The Pharmacogenomics and Oncology Communities are hosting a joint meeting to identify the strengths, weaknesses, opportunities, and threats at the interface of Pharmacogenomics and Oncology. Our agenda will include a look back at 2018 Community accomplishments, a roundtable discussion to identify possible future shared activities, and an informal joint Communities networking event. We are excited to offer presentations by young investigators in our fields and by Dr. Rebecca Blanchard, Vice President of Translational Pharmacology at CRISPR Therapeutics, who will discuss the value of pharmacogenomics and exploratory biomarker research in oncology.

Oncology Community Hosted Lunch Table
Friday, March 15 (12:00 pm - 1:00 pm)
Washington 2-6
Grab your lunch and join ASCPT Network, Community and Journal leaders for small group, informal networking discussions over the lunch break. Learn more about ASCPT initiatives, the Family of Journals, 2020 planning, how you can become more involved in the Society, and much more!

Past Webinars
  • IQ CPLG PWG: Strategies to Address Opportunities in Oncology Pediatric Drug
  • Clinical Pharmacological and Pharmacodynamic Perspectives on the Adverse Events of Cancer Immunotherapy
  • Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Cancer Patients
Community Working Groups
Communications Working Group
Goals: Identify the communications tools, shared content and frequency desired by Community members.
Identify a means for Community members to identify content (publications, presentation links, etc.) for consideration.
Shruti Agrawal, PhD, Working Group Lead
Antoinette Ajavon, PhD, Working Group Member

Forum Working Group 
Goals: Identify the forum (webinar, local face-to-face meetings, etc) structure desired by Community members.
Identify the frequency and timeframe for the forum desired by Community members.
Angela James, PhD, Working Group Lead
Yan Ji, PhD, Working Group Member
Imke Bartelink, PharmD, PhD, Working Group Member
If you are interested in volunteering with the ONC working group, please email Stacy.

Mark Stroh, PhD

Community Chair


Shruti Agrawal, PhD

Community Vice Chair


Stacy Shord, PharmD

Community Past Chair


Angela James, PhD

Working Group Lead


Photo Gallery
Recent News
Contact Us